Literature DB >> 17689771

Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties.

Kafai Lai1, Eric R Bohm, Colin Burnell, David R Hedden.   

Abstract

Many older patients undergoing primary hip or knee joint arthroplasty surgery have multiple medical problems. In this retrospective case-control study, the authors examined the individual and cumulative effects of various types of medical comorbidities on the risk of developing prosthetic joint infection after surgery. Case and control patients were matched by age, sex, and procedure. Analysis was undertaken using crude odds ratios (ORs) and multiple logistic regression analysis. Fifty-one patients with 52 joint infections were identified. Both diabetes mellitus (OR, 3.91; P = .04) and total number of medical conditions (OR, 1.35; P = .005) were associated with higher risk of infection. This information allows the orthopedic surgeon to inform patients more fully regarding the risks of surgery, and promotes the reduction and optimization of medical comorbidities before surgery.

Entities:  

Mesh:

Year:  2007        PMID: 17689771     DOI: 10.1016/j.arth.2006.09.002

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  39 in total

1.  Incidence, surgical procedures, and outcomes of hip fracture among elderly type 2 diabetic and non-diabetic patients in Spain (2004-2013).

Authors:  A Lopez-de-Andrés; R Jiménez-García; I Jiménez-Trujillo; V Hernández-Barrera; J M de Miguel-Yanes; M Méndez-Bailón; N Perez-Farinos; J de Miguel-Diez; M Á Salinero-Fort; P Carrasco-Garrido
Journal:  Osteoporos Int       Date:  2015-08-29       Impact factor: 4.507

2.  Does adding antibiotics to cement reduce the need for early revision in total knee arthroplasty?

Authors:  Eric Bohm; Naisu Zhu; Jing Gu; Nicole de Guia; Cassandra Linton; Tammy Anderson; David Paton; Michael Dunbar
Journal:  Clin Orthop Relat Res       Date:  2014-01       Impact factor: 4.176

3.  The ACS NSQIP Risk Calculator Is a Fair Predictor of Acute Periprosthetic Joint Infection.

Authors:  Nathaniel C Wingert; James Gotoff; Edgardo Parrilla; Robert Gotoff; Laura Hou; Elie Ghanem
Journal:  Clin Orthop Relat Res       Date:  2016-07       Impact factor: 4.176

4.  Retrospective analysis of infection rate after early reoperation in total hip arthroplasty.

Authors:  Hussein Darwiche; Wael K Barsoum; Alison Klika; Viktor E Krebs; Robert Molloy
Journal:  Clin Orthop Relat Res       Date:  2010-09       Impact factor: 4.176

5.  Reducing periprosthetic joint infection: what really counts?

Authors:  Giuseppe Solarino; Antonella Abate; Giovanni Vicenti; Antonio Spinarelli; Andrea Piazzolla; Biagio Moretti
Journal:  Joints       Date:  2016-01-31

6.  Are antibiotics necessary in hip arthroplasty with asymptomatic bacteriuria? Seeding risk with/without treatment.

Authors:  José Cordero-Ampuero; Enrique González-Fernández; David Martínez-Vélez; Jaime Esteban
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

Review 7.  The challenge of infection prevention in spine surgery: an update.

Authors:  T Ferry; F Valour; S Lustig; F Laurent; G Perrin; C Chidiac; C Barrey
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-05-21

8.  Forgotten intrauterine contraceptive device - A threat to total hip prosthesis: A case report with review of the literature.

Authors:  Sonam Sharma; Sansar Chand Sharma
Journal:  J Clin Orthop Trauma       Date:  2015-11-27

9.  Does preoperative American Society of Anesthesiologists score relate to complications after total shoulder arthroplasty?

Authors:  Christine C Johnson; Sonal Sodha; Juan Garzon-Muvdi; Steve A Petersen; Edward G McFarland
Journal:  Clin Orthop Relat Res       Date:  2013-12-10       Impact factor: 4.176

10.  Outcomes of shoulder arthroplasty in diabetic patients as assessed by peri-operative A1C.

Authors:  Joseph M Statz; Eric R Wagner; John W Sperling; Robert H Cofield
Journal:  Int Orthop       Date:  2018-03-18       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.